Back
Ascendis Pharma AS Stock Price Chart
Sponsored
ASND
Sponsored
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Sell
45
ASND
Ascendis Pharma AS
Last Price:
$138.77
Seasonality Move:
19.34%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ASND is experiencing slight buying pressure.
Ascendis Pharma AS Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 136.91 | Buy |
20-day SMA: | 134.51 | Buy |
50-day SMA: | 130 | Buy |
200-day SMA: | 135.14 | Buy |
8-day EMA: | 136.98 | Buy |
20-day EMA: | 134.41 | Buy |
50-day EMA: | 132.52 | Buy |
200-day EMA: | 131.03 | Buy |
Ascendis Pharma AS Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.31 | Buy |
Relative Strength Index (14 RSI): | 58.15 | Buy |
Chaikin Money Flow: | 19027 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (128.35 - 137.43) | Buy |
Bollinger Bands (100): | (123.97 - 141.13) | Buy |
Ascendis Pharma AS Technical Analysis
Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Ascendis Pharma AS Stock
Is Ascendis Pharma AS Stock a Buy?
-
Ascendis Pharma AS share price is 138.79 while ASND 8-day simple moving average is 136.91, which is a Buy signal.
-
The stock price of ASND is 138.79 while Ascendis Pharma AS 20-day SMA is 134.51, which makes it a Buy.
-
Ascendis Pharma AS 50-day simple moving average is 130.00 while ASND share price is 138.79, making it a Buy technically.
-
ASND stock price is 138.79 and Ascendis Pharma AS 200-day simple moving average is 135.14, creating a Buy signal.
ASND Technical Analysis vs Fundamental Analysis
Sell
45
Ascendis Pharma AS (ASND)
is a Sell
Is Ascendis Pharma AS a Buy or a Sell?
-
Ascendis Pharma AS stock is rated a SellThe current Ascendis Pharma AS [ASND] share price is $138.79. The Score for ASND is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
Ascendis Pharma AS Stock Info
Market Cap:
8.3B
Price in USD:
138.79
Share Volume:
72.2K
Ascendis Pharma AS 52-Week Range
52-Week High:
161.00
52-Week Low:
111.09
Sell
45
Ascendis Pharma AS (ASND)
is a Sell
Ascendis Pharma AS Share Price Forecast
-
What is the Ascendis Pharma AS stock price today?The Ascendis Pharma AS stock price is 138.79 USD today.
-
Will ASND stock go up or go down?Ascendis Pharma AS> share price is forecast to RISE/FALL based on technical indicators
-
Is Ascendis Pharma AS overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Ascendis Pharma AS is overvalued.
Is Ascendis Pharma AS Stock a Buy?
-
Ascendis Pharma AS share price is 138.79 while ASND 8-day exponential moving average is 136.98, which is a Buy signal.
-
The stock price of ASND is 138.79 while Ascendis Pharma AS 20-day EMA is 134.41, which makes it a Buy.
-
Ascendis Pharma AS 50-day exponential moving average is 132.52 while ASND share price is 138.79, making it a Buy technically.
-
ASND stock price is 138.79 and Ascendis Pharma AS 200-day simple moving average is 131.03, creating a Buy signal.
Fundamental Analysis of Ascendis Pharma AS
Is Ascendis Pharma AS a good investment?
-
Analysts estimate an earnings increase this quarter of $0.48 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.98 per share, and an increase next year of $3.81 per share.
Technical Analysis of Ascendis Pharma AS
Should I short Ascendis Pharma AS stock?
-
ASND Moving Average Covergence Divergence (MACD) indicator is 2.31, suggesting Ascendis Pharma AS is a Buy
-
Ascendis Pharma AS Relative Strength Index (RSI) is 58.15, which suggest Ascendis Pharma AS is overbought
-
The Bollinger Bands (25) for Ascendis Pharma AS is (128.35 - 137.43), which suggest Ascendis Pharma AS is a Buy
-
The Bollinger Bands (100) for Ascendis Pharma AS is (123.97 - 141.13), which suggest Ascendis Pharma AS is a Buy
* Ascendis Pharma AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.